Literature DB >> 17491057

Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.

S Leyvraz.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17491057     DOI： 10.1093/annonc/mdm046

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  [Consensus diagnosis and therapy of soft tissue sarcoma].

Authors:  Thomas Brodowicz; Gabriele Amann; Andreas Leithner; Arpad Sztankay; Franz Kainberger; Wolfgang Eisterer; Bernadette Liegl-Atzwanger; Franz Rachbauer; Thomas Rath; Michael Bergmann; Philipp T Funovics; Ferdinand Ploner; Reinhard Windhager
Journal:  Wien Klin Wochenschr       Date:  2011-10-28       Impact factor: 1.704

Review 2.  Trabectedin : a review of its use in the management of soft tissue sarcoma and ovarian cancer.

Authors:  Natalie J Carter; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information.

Authors:  E J O Soini; B García San Andrés; T Joensuu
Journal:  Ann Oncol       Date:  2010-07-13       Impact factor: 32.976

4.  Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS).

Authors:  Isabelle Ray-Coquard; Olivier Collard; Françoise Ducimetiere; Mathieu Laramas; Florence Mercier; Nadine Ladarre; Stephanie Manson; Bertrand Tehard; Sébastien Clippe; Jean-Philippe Suchaud; Laetitia Stefani; Jean-Yves Blay
Journal:  BMC Cancer       Date:  2017-02-07       Impact factor: 4.430

5.  Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000-2017 Netherlands Cancer Registry Database Analysis.

Authors:  Milan Van Meekeren; Marta Fiocco; Vincent K Y Ho; Judith V M G Bovée; Hans Gelderblom; Rick L Haas
Journal:  Sarcoma       Date:  2021-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.